Spore-Based Probiotic Composition for Canine Endotoxemia Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address endotoxemia and digestive disorders in dogs, a condition characterized by increased serum endotoxin levels affecting gastrointestinal permeability and microbiota, with limited understanding of naturally occurring endotoxemia in canines.
Innovation Solution
Administering a probiotic composition comprising Bacillus subtilis, Bacillus licheniformis, and Pediococcus acidilactici to dogs, specifically using spore-based strains like Bacillus subtilis HU58 and Bacillus licheniformis SL-307, to decrease endotoxemia and improve digestion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional probiotics (Lactobacillus and Bifidobacterium) are used, then they provide beneficial effects in human studies, but they show limited efficacy in dogs and do not effectively address endotoxemia
Solution Approach 1:
The patent applies local quality by selecting probiotic strains specifically adapted to the canine gastrointestinal environment. Instead of using universal human probiotics, the invention uses Bacillus subtilis, Bacillus licheniformis, and Pediococcus acidilactici strains that are known to be effective in dogs, thereby optimizing probiotic efficacy for the specific host species.
Solution Approach 2:
The patent employs parameter changes by transitioning from human-centric probiotic strains to canine-specific strains. This involves changing the strain selection parameters based on species-specific gastrointestinal physiology, pH levels, and microbiota composition, which explains the superior efficacy in dogs compared to conventional human probiotics.
2Reliability
If spore-based Bacillus strains are used, then they exhibit higher viability and reproduce in the GI tract under unfavorable conditions, but they require specific strain selection (HU58, SL-307) to ensure effectiveness
Solution Approach 1:
The patent applies preliminary action by pre-selecting and characterizing specific Bacillus strains (HU58, SL-307) before inclusion in the probiotic composition. These strains have been预先 evaluated for their ability to survive gastric acid, adhere to intestinal mucus, and reproduce in the canine GI tract, ensuring effectiveness before administration.
Solution Approach 2:
The patent uses spore formation as an intermediary mechanism to protect the bacterial cells during transit through the acidic stomach environment. The spores act as a protective载体 that delivers viable bacteria to the intestine, where they then germinate and establish themselves in the gut microbiota.
3Object-affected harmful factors
If probiotics are administered to decrease endotoxemia, then intestinal barrier function is enhanced, but the mechanism by which this occurs is not fully understood in canine models
Solution Approach 1:
The patent employs feedback by measuring endotoxin levels and intestinal barrier parameters before and after probiotic administration in canine studies. This feedback loop allows the researchers to observe the correlation between probiotic intake, changes in intestinal permeability, and reductions in serum endotoxin levels, thereby elucidating the mechanism of action.
Solution Approach 2:
The patent replaces direct mechanical intervention (such as surgery or invasive procedures) with a biological mechanism-based approach. Instead of physically repairing the intestinal barrier, the probiotics work through biological mechanisms including production of short-chain fatty acids, stimulation of mucin secretion, and modulation of tight junction proteins, which naturally strengthens the barrier function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The probiotic composition significantly reduces endotoxemia and improves digestive health in dogs, including those with gastrointestinal disorders, by enhancing intestinal barrier function and modulating the gut microbiota.
Implementation Method 1
probiotics may modulate the frequency of the tight junction proteins that act as a barrier in the intestinal paracellular pathway. By enhancing intestinal barrier function, probiotics serve as preventative agents to defend against adverse effects of pathogens
Implementation Method 2
increased mucin secretion by goblet cells
Implementation Method 3
increased short-chain fatty acid production
Implementation Method 4
stimulation of IgA secretion
Implementation Method 5
decreased luminal pH
Data Source
AI summary
The present invention is directed to methods of administering a probiotic composition including Bacillus subtilis, Bacillus licheniformis, and Pediococcus acidilactici to dogs to decrease endotoxemia and improve the digestive process, and related methods.